SynthesisThe Cochrane database of systematic reviews2001
Medicinal herbs for hepatitis C virus infection.
Synthesis in The Cochrane database of systematic reviews, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 37 citations in OpenAlex.
- Pooled it
- Pharmacological interventions for ischaemia reperfusion injury in liver resection surgery performed under vascular control.The Cochrane database of systematic reviews · 2009Pooled it
- Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial.World journal of gastroenterology · 2007Trial
- Safety and efficacy of Qurse-e-istisqua in chronic hepatitis C infection: an exploratory study.Indian journal of pharmacologyTrial
- Knowledge of hepatitis C and awareness of reinfection risk among people who successfully completed direct acting antiviral therapy.PloS one · 2022Article
- The Cochrane Review Conclusion for Hepatitis C DAA Therapies is Wrong.The American journal of gastroenterology · 2018Article
- Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders.World journal of gastroenterology · 2015Review
- An antioxidant resveratrol significantly enhanced replication of hepatitis C virus.World journal of gastroenterology · 2010Article
- Evidence from the Cochrane Collaboration for Traditional Chinese Medicine therapies.Journal of alternative and complementary medicine (New York, N.Y.) · 2009Review
- Complementary and alternative medicine use by patients chronically infected with hepatitis C virus.Canadian journal of gastroenterology = Journal canadien de gastroenterologie · 2007Article
- Complementary and alternative medicine in the treatment of chronic liver disease.Current gastroenterology reports · 2005Review
- Severe acute respiratory syndrome (SARS)--paradigm of an emerging viral infection.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2004Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatitis C virus (HCV) infection is a serious health problem world-wide. Medicinal herbs are increasingly being used for hepatitis C.
objectivesTo assess the efficacy and safety of medicinal herbs for hepatitis C virus infection. SEARCH STRATEGY: Searches were applied to The Controlled Trial Registers of The Cochrane Hepato-Biliary Group, The Cochrane Complementary Medicine Field, and The Cochrane Library as well as MEDLINE, EMBASE, BIOSIS, Chinese and Japanese databases. Five Chinese journals and one Japanese journal were handsearched. No language restriction was used. SELECTION CRITERIA: Randomised clinical trials comparing medicinal herbs (single herb or compound of herbs) versus placebo, no intervention, general non-specific treatment, other herbal medicine, or interferon and/or ribavirin treatment. Trials of medicinal herbs plus interferon and/or ribavirin versus interferon and/or ribavirin alone were also included. Trials could be double-blind, single-blind, or unblinded. DATA COLLECTION AND ANALYSIS: Data were extracted independently by two reviewers. The methodological quality of the trials was evaluated using the generation of allocation sequence, allocation concealment, double blinding, and the Jadad-scale. The outcomes were presented as relative risk or weighted mean difference, both with 95% confidence interval. MAIN
resultsTen randomised trials, including 517 patients with mainly chronic hepatitis C, evaluated ten different medicinal herbs versus various control interventions (four placebo, four interferon, two other herbs). The methodological quality was considered adequate in four trials and inadequate in six trials. Compared with placebo in four trials, none of the medicinal herbs showed positive effects on clearance of serum HCV RNA or anti-HCV antibody or on serum liver enzymes, except one short-term trial in which a silybin preparation showed a significant effect on reducing serum aspartate aminotransferase and gamma-glutamyltranspeptidase activities. The herbal compound Bing Gan Tang combined with interferon-alpha showed significantly better effects on clearance of serum HCV RNA (relative risk 2.54; 95% confidence interval 1.43 to 4.49) and on normalisation of serum alanine aminotransferase activity (relative risk 2.54; 95% confidence interval 1.43 to 4.49) than interferon-alpha monotherapy. The herbal compound Yi Zhu decoction showed a significant effect on clearance of serum HCV RNA and normalisation of ALT levels compared to glycyrrhizin plus ribavirin. Yi Er Gan Tang showed a significant effect on normalising serum alanine aminotransferase compared to silymarin plus glucurolactone. There was no significant efficacy of the other examined herbs. The herbs were associated with adverse events. REVIEWER'S
conclusionsThere is no firm evidence of efficacy of any medicinal herbs for HCV infection. Medicinal herbs for HCV infection should not be used outside randomised clinical trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.